|1.||Stein, Dan J: 20 articles (04/2013 - 01/2002)|
|2.||Fava, Maurizio: 19 articles (02/2015 - 03/2002)|
|3.||Hollander, Eric: 18 articles (03/2014 - 10/2002)|
|4.||Papakostas, George I: 16 articles (02/2014 - 02/2004)|
|5.||Thase, Michael E: 15 articles (01/2014 - 01/2005)|
|6.||Denys, Damiaan: 14 articles (09/2013 - 08/2002)|
|7.||Kasper, Siegfried: 13 articles (08/2015 - 01/2002)|
|8.||Barbui, Corrado: 9 articles (09/2015 - 05/2005)|
|9.||Koyama, Tsukasa: 9 articles (01/2015 - 06/2004)|
|10.||Koran, Lorrin M: 9 articles (08/2011 - 09/2002)|
|1.||Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
07/01/2006 - "Cognitive-behavioral group therapy (CBGT) and serotonin reuptake inhibitors have proven efficacy in reducing symptoms of obsessive-compulsive disorder (OCD). "
01/01/2004 - "Serotonin reuptake inhibitors (SRIs), especially potent ones given at high doses over long periods of time, are often effective in the treatment of obsessive-compulsive disorder (OCD). "
01/01/1998 - "Potent serotonin reuptake inhibitors and behavior therapy involving exposure and ritual prevention have been established as the cornerstones of effective treatment for obsessive-compulsive disorder. "
02/01/2010 - "In the last decades, the treatment of obsessive-compulsive disorder (OCD) has improved significantly with the introduction into the clinical practice of the selective serotonin reuptake inhibitors (SSRIs): this has led to a renewed interest in this condition and development of appropriate therapeutic strategies, including non-pharmacological techniques. "
03/01/2007 - "There is good evidence to support the efficacy of several pharmacological agents including the selective serotonin reuptake inhibitors to treat pediatric anxiety and obsessive-compulsive disorder, although there are still many unanswered questions."
|2.||Anxiety Disorders (Anxiety Disorder)
01/01/2012 - "Since 1980s, several clinical trials have shown that selective serotonin reuptake inhibitors (SSRIs), which have no dependency, are effective for most subtypes of anxiety disorders. "
08/30/2004 - "Selective serotonin reuptake inhibitors are first-line treatment for most anxiety disorders, but their mechanism of anxiolytic action has not been clarified. "
05/01/2002 - "Most recent data concerning the efficacy of selective serotonin reuptake inhibitors suggests that these agents will be effective and safe in the treatment of paediatric anxiety disorders. "
01/01/2011 - "On the positive side, a considerable database of studies shows efficacy and relative tolerability of the selective serotonin reuptake inhibitors in the major anxiety disorders, and secondary analyses of such datasets have informed questions such as optimal definition of response and remission, optimal dose and duration, and comparative efficacy of different agents. "
01/15/2010 - "Area-specific and stimulation-dependent changes of human brain activation by selective serotonin reuptake inhibitors (SSRI) are an important issue for improved understanding of treatment mechanisms, given the frequent prescription of these drugs in depression and anxiety disorders. "
|3.||Major Depressive Disorder (Major Depressive Disorders)
01/01/2013 - "Selective serotonin reuptake inhibitors (SSRIs) are the most used and the most cost-effective treatment for long-term major depressive disorder. "
12/01/2005 - "Although serotonin reuptake inhibitors are recommended as first-line agents for major depressive disorder, delayed onset of action is problematic, and faster effective treatment is needed. "
08/30/2002 - "Recently, it was reported that selective serotonin reuptake inhibitors were more effective in patients with major depressive disorder having the homozygous allele pair (12-copy/12-copy) of VNTR in the STin2 than in ones having other allele combinations. "
01/01/2008 - "Selective serotonin reuptake inhibitors are a modestly effective and generally safe treatment for postpubertal major depressive disorder, but their use requires collaborative decision making and a predetermined, shared monitoring plan."
02/28/2015 - "The acute efficacy of selective serotonin reuptake inhibitors (SSRIs) in the treatment of major depressive disorder (MDD) is well established; however their role in longer-term prevention of recurrence remains unconfirmed. "
|4.||Panic Disorder (Panic Attack)
10/01/2000 - "The discussion underscores the need for more methodologically improved comparative studies with selective serotonin reuptake inhibitors in the treatment of panic disorder."
02/01/2007 - "Selective serotonin reuptake inhibitors are thought to interact with serotonergic neurons and be effective for treatment of panic disorder. "
09/01/2002 - "Both cognitive-behavioral therapy and treatment with selective serotonin reuptake inhibitors (SSRIs) have proved to be effective in the treatment of panic disorder. "
12/01/2001 - "Although serotonin reuptake inhibitors are effective in panic disorder, questions concerning whether doses associated with antidepressant efficacy are also effective for panic disorder remain. "
04/01/1998 - "Of the therapeutic options available, there is mounting evidence that selective serotonin reuptake inhibitors (SSRIs) represent reasonable monotherapy for patients with comorbid depression and panic disorder, based on the equivalent efficacy and improved side-effect profiles compared with other classes of antidepressant. "
|5.||Post-Traumatic Stress Disorders (PTSD)
01/01/2004 - "Although acute treatment with selective serotonin reuptake inhibitors (SSRIs) has been shown to be effective, successful strategies for preventing PTSD have not been established. "
01/01/2014 - "Although selective serotonin reuptake inhibitors are effective in improving PTSD global symptoms, they have a variable and modest effect on sleep disorder symptoms. "
11/01/2002 - "Considering reported overall efficacy and side effects profiles, selective serotonin reuptake inhibitors emerge as the preferred first line treatment for PTSD. "
08/01/2001 - "The emergence of consistent data suggesting that medications (selective serotonin reuptake inhibitors) and psychotherapies (cognitive-behavior therapy) are effective in reducing core symptoms and improving quality of life, has reinforced optimism and more widespread use of these interventions in patients with PTSD."
01/01/2009 - "Although selective serotonin reuptake inhibitors (SSRIs) are reported to be effective in decreasing posttraumatic stress disorder (PTSD) symptoms, a subgroup of PTSD patients remain chronically symptomatic and maintain conditioned fear responses to traumatic stimuli. "
|1.||Serotonin (5 Hydroxytryptamine)
|3.||Antidepressive Agents (Antidepressants)
|4.||Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
|9.||Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
|1.||Drug Therapy (Chemotherapy)
|2.||Cardiac Resynchronization Therapy
|5.||Renal Dialysis (Hemodialysis)